(0.25%) 5 144.50 points
(0.27%) 38 544 points
(0.36%) 17 910 points
(-0.82%) $83.16
(1.25%) $1.947
(-0.12%) $2 344.50
(1.22%) $27.59
(0.69%) $928.50
(-0.29%) $0.932
(-0.33%) $10.99
(-0.40%) $0.797
(0.85%) $92.66
Live Chart Being Loaded With Signals
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use...
Stats | |
---|---|
本日の出来高 | 21 695.00 |
平均出来高 | 11 031.00 |
時価総額 | 68.48M |
EPS | $0 ( 2024-04-19 ) |
次の収益日 | ( $0.0400 ) 2024-07-12 |
Last Dividend | $0.900 ( 2022-09-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | -7.28 |
ATR14 | $0.0920 (1.09%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-22 | Portnoy Mark L. | Buy | 25 000 | Stock Option |
2023-12-22 | Mikulinsky Oleg | Buy | 10 000 | Stock Option |
2023-12-22 | Taymans Jill M | Buy | 10 000 | Stock Option |
2023-12-22 | Portnoy David | Buy | 50 000 | Stock Option |
2023-10-10 | Berger Harold D. | Buy | 5 300 | Stock Option |
INSIDER POWER |
---|
81.72 |
Last 100 transactions |
Buy: 2 158 485 | Sell: 773 682 |
Cryo-Cell International, 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Cryo-Cell International, 財務諸表
Annual | 2023 |
収益: | $31.34M |
総利益: | $22.90M (73.07 %) |
EPS: | $-1.140 |
FY | 2023 |
収益: | $31.34M |
総利益: | $22.90M (73.07 %) |
EPS: | $-1.140 |
FY | 2022 |
収益: | $30.34M |
総利益: | $21.54M (71.02 %) |
EPS: | $0.330 |
FY | 2021 |
収益: | $28.88M |
総利益: | $19.90M (68.88 %) |
EPS: | $0.260 |
Financial Reports:
No articles found.
Cryo-Cell International, Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.900 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.900 | 2022-09-01 |
Last Dividend | $0.900 | 2022-09-01 |
Next Dividend | $0 | N/A |
Payout Date | 2022-09-09 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.900 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 0.32 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 2.13 | |
Div. Directional Score | 1.037 | -- |
Year | Amount | Yield |
---|
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
PKKW | Ex Dividend Junior | 2023-09-07 | Semi-Annually | 0 | 0.00% | |
HRNNF | Ex Dividend Knight | 2023-09-12 | Quarterly | 0 | 0.00% | |
ENBP | Ex Dividend Knight | 2023-08-14 | Quarterly | 0 | 0.00% | |
CMTV | Ex Dividend Knight | 2023-10-12 | Quarterly | 0 | 0.00% | |
TNCAF | Ex Dividend Junior | 2023-08-30 | Quarterly | 0 | 0.00% | |
RSKIA | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
NUVR | Ex Dividend Junior | 2023-06-02 | Quarterly | 0 | 0.00% | |
FMFG | Ex Dividend Knight | 2023-06-01 | Semi-Annually | 0 | 0.00% | |
CZFS | Ex Dividend Knight | 2023-09-14 | Quarterly | 0 | 0.00% | |
WCRS | Ex Dividend Junior | 2023-08-21 | Quarterly | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.310 | 1.500 | -6.20 | -9.31 | [0 - 0.5] |
returnOnAssetsTTM | -0.158 | 1.200 | -5.26 | -6.31 | [0 - 0.3] |
returnOnEquityTTM | 1.750 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0.488 | 0.800 | -2.56 | -2.05 | [1 - 3] |
quickRatioTTM | 0.398 | 0.800 | -2.37 | -1.892 | [0.8 - 2.5] |
cashRatioTTM | 0.0128 | 1.500 | -1.040 | -1.560 | [0.2 - 2] |
debtRatioTTM | 0.187 | -1.500 | 6.88 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -12.82 | 1.000 | -5.86 | -5.86 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.838 | 2.00 | 9.72 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.0972 | 2.00 | -0.0486 | -0.0972 | [0 - 20] |
debtEquityRatioTTM | -1.118 | -1.500 | -4.47 | 6.71 | [0 - 2.5] |
grossProfitMarginTTM | 0.728 | 1.000 | 1.201 | 1.201 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.420 | 1.000 | -10.00 | -10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.599 | 1.000 | 7.78 | 7.78 | [0.2 - 2] |
assetTurnoverTTM | 0.508 | 0.800 | 9.94 | 7.96 | [0.5 - 2] |
Total Score | -0.0519 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -7.17 | 1.000 | -0.825 | 0 | [1 - 100] |
returnOnEquityTTM | 1.750 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.0972 | 2.00 | -0.0324 | -0.0972 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.838 | 2.00 | 9.72 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.0161 | 1.500 | -3.23 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.221 | 1.000 | 6.99 | 0 | [0.1 - 0.5] |
Total Score | 2.13 |
Cryo-Cell International,
Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It stores approximately 500,000 cord blood and cord tissue stem cells worldwide. The company markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。